Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPD
Clinical trial NCT02766608 · COMPLETED
Trial details
- NCT number
- NCT02766608
- Sponsor
- Pearl Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-31
- Primary completion
- 2017-12-01
- Enrollment
- 2389
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.